We are live on ! Find out more
MD icon

Pediatrix Medical

218 hedge funds and large institutions have $995M invested in Pediatrix Medical in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 78 increasing their positions, 78 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

580% more call options, than puts

Call options by funds: $401K | Put options by funds: $59K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

51% more capital invested

Capital invested by funds: $659M → $995M (+$337M)

0% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 78

3.64% less ownership

Funds ownership: 103.74%100.11% (-3.6%)

4% less funds holding

Funds holding: 227218 (-9)

26% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 34

Holders
218
Holders Change
-9
Holders Change %
-3.96%
% of All Funds
3.13%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
25
Increased
78
Reduced
78
Closed
34
Calls
$401K
Puts
$59K
Net Calls
+$342K
Net Calls Change
+$226K
Name Holding Trade Value Shares
Change
Change in
Stake
VA
101
Vident Advisory
Georgia
$486K +$395K +41,893 New
Susquehanna International Group
102
Susquehanna International Group
Pennsylvania
$484K -$821K -87,053 -68%
LSERS
103
Louisiana State Employees Retirement System
Louisiana
$474K -$7.54K -800 -2%
SOW
104
State of Wyoming
Wyoming
$473K +$131K +13,924 +52%
Millennium Management
105
Millennium Management
New York
$473K -$997K -105,731 -72%
IIM
106
INTECH Investment Management
Florida
$471K +$87.6K +9,289 +30%
GAM
107
Gotham Asset Management
New York
$459K +$373K +39,598 New
Victory Capital Management
108
Victory Capital Management
Texas
$453K -$59.8K -6,339 -14%
LCM
109
Legato Capital Management
California
$451K
SCM
110
Sterling Capital Management
North Carolina
$443K +$360K +38,206 New
Marshall Wace
111
Marshall Wace
United Kingdom
$398K -$942K -99,891 -74%
Janus Henderson Group
112
Janus Henderson Group
United Kingdom
$397K
BA
113
Bridgewater Associates
Connecticut
$381K -$341K -36,167 -52%
Manulife (Manufacturers Life Insurance)
114
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$366K -$7.26K -770 -2%
Creative Planning
115
Creative Planning
Kansas
$355K +$94.2K +9,991 +48%
MSRPS
116
Maryland State Retirement & Pension System
Maryland
$335K
VOYA Investment Management
117
VOYA Investment Management
Georgia
$327K -$4.51K -478 -2%
Comerica Bank
118
Comerica Bank
Texas
$321K +$14.1K +1,497 +6%
BHCM
119
Brevan Howard Capital Management
Jersey
$320K -$87.5K -9,277 -25%
IC
120
IEQ Capital
California
$320K +$5.81K +616 +2%
TRSOTSOK
121
Teachers Retirement System of the State of Kentucky
Kentucky
$315K
AI
122
Atria Investments
North Carolina
$314K +$21.1K +2,238 +9%
CC
123
Centiva Capital
New York
$310K +$48.3K +5,124 +24%
YCM
124
Yousif Capital Management
Michigan
$308K +$94 +10 +0%
AB
125
Amalgamated Bank
New York
$289K +$3.79K +402 +2%

MD Hedge Fund Activity: Q3 2024 in Review

218 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2024, worth a combined $995M — up 51% from $659M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of MD and 25 opened new positions — a net loss of 9 holders — while 78 trimmed existing stakes and 78 added.

The largest buyer was Caspian Capital, adding an estimated $6.27M. The largest seller was Norges Bank, cutting an estimated $4.79M.

  • 218 institutional investors held Pediatrix Medical (MD) as of Q3 2024, down from 227 in Q2 2024.
  • Funds reported $995M of Pediatrix Medical stock for Q3 2024, up 51% quarter-over-quarter.
  • 25 funds opened new Pediatrix Medical positions in Q3 2024 and 34 closed out, a net change of -9 holders.
  • The largest Pediatrix Medical buyer in Q3 2024 was Caspian Capital, an estimated $6.27M added.
  • The largest Pediatrix Medical seller in Q3 2024 was Norges Bank, an estimated $4.79M sold.

Based on aggregated 13F filings for Q3 2024.